Wilbur B. Bowne

5.7k total citations · 1 hit paper
115 papers, 3.9k citations indexed

About

Wilbur B. Bowne is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Wilbur B. Bowne has authored 115 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 46 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in Wilbur B. Bowne's work include Pancreatic and Hepatic Oncology Research (32 papers), Intraperitoneal and Appendiceal Malignancies (16 papers) and Pancreatitis Pathology and Treatment (13 papers). Wilbur B. Bowne is often cited by papers focused on Pancreatic and Hepatic Oncology Research (32 papers), Intraperitoneal and Appendiceal Malignancies (16 papers) and Pancreatitis Pathology and Treatment (13 papers). Wilbur B. Bowne collaborates with scholars based in United States, New Zealand and Japan. Wilbur B. Bowne's co-authors include Murray F. Brennan, Jonathan J. Lewis, David P. Jaques, Peter J. Allen, Klaus J. Busam, Daniel G. Coit, William G. Hawkins, Alan N. Houghton, Jedd D. Wolchok and Roopa Srinivasan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Wilbur B. Bowne

102 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution

2005 533 citations Peter J. Allen, Wilbur B. Bowne et al. profile →

Peers

Countries citing papers authored by Wilbur B. Bowne

Since Specialization

Citations

This map shows the geographic impact of Wilbur B. Bowne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilbur B. Bowne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilbur B. Bowne more than expected).

Fields of papers citing papers by Wilbur B. Bowne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilbur B. Bowne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilbur B. Bowne. The network helps show where Wilbur B. Bowne may publish in the future.

Co-authorship network of co-authors of Wilbur B. Bowne

This figure shows the co-authorship network connecting the top 25 collaborators of Wilbur B. Bowne. A scholar is included among the top collaborators of Wilbur B. Bowne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilbur B. Bowne. Wilbur B. Bowne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlation of GNAS Mutational Status with Oncologic Outcomes in Patients with Resected Intraductal Papillary Mucinous Neoplasms 2025 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Wilbur B. Bowne, Aditi Jain, Harish Lavu, Charles J. Yeo, Avinoam Nevler	1
2	Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Aditi Jain, (unknown), Wilbur B. Bowne, Harish Lavu, Charles J. Yeo, Avinoam Nevler	0
3	Major Pancreatic Resection Increases Bone Mineral Density Loss, Osteoporosis, and Fractures 2024 ·Annals of Surgery ·(unknown), (unknown), (unknown), (unknown), (unknown), Theresa P. Yeo, Harish Lavu, Wilbur B. Bowne, Charles J. Yeo, Avinoam Nevler	0
4	Incisional hernia after major pancreatic resection: long term risk assessment from two distinct sources – A large multi-institutional network and a single high-volume center 2024 ·HPB ·(unknown), (unknown), Theresa P. Yeo, Harish Lavu, Wilbur B. Bowne, Charles J. Yeo, Avinoam Nevler	0
5	Impact of antecolic vs transmesocolic reconstruction on delayed gastric emptying following pancreaticoduodenectomy 2024 ·Journal of Gastrointestinal Surgery ·(unknown), (unknown), (unknown), Hui Chen, (unknown), Harish Lavu, Wilbur B. Bowne, Charles J. Yeo, Avinoam Nevler	0
6	Contemporary report of surgical outcomes after single‐stage total pancreatectomy: A 10‐year experience 2024 ·Journal of Surgical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Ryan Lamm, John Williamson, Avinoam Nevler, Harish Lavu, Warren R. Maley, Charles J. Yeo, Wilbur B. Bowne	0
7	Implementation of an opioid reduction toolkit in pancreatectomy patients significantly increases patient awareness of safe practice and decreases amount prescribed and consumed 2023 ·HPB ·Ryan Lamm, (unknown), (unknown), (unknown), (unknown), John Williamson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Wilbur B. Bowne, Avinoam Nevler, Scott W. Cowan, Theresa P. Yeo, Charles J. Yeo, Harish Lavu	1
8	Salvage endoscopic ultrasound-guided gastrojejunostomy as a bridge to definitive surgical therapy for duodenal adenocarcinoma presenting with duodenal stent obstruction 2023 ·Clinical Journal of Gastroenterology ·(unknown), (unknown), Richard Zheng, Babar Bashir, (unknown), Charles J. Yeo, Avinoam Nevler, Harish Lavu, Wilbur B. Bowne, Anand Kumar	1
9	Non-thermal plasma-induced immunogenic cell death in cancer 2019 ·Journal of Physics D Applied Physics ·(unknown), (unknown), Abraham Lin, Fred C. Krebs, Adam E. Snook, Sander Bekeschus, Wilbur B. Bowne, Vandana Miller	75
10	Patient-specific predictors of failure to rescue after major hepatectomy 2018 ·HPB ·Elizabeth Gleeson, Wilbur B. Bowne, Henry A. Pitt	1
11	Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas 2017 ·Case Reports in Oncological Medicine ·(unknown), William F. Morano, (unknown), Hui Li, (unknown), Jaganmohan Poli, Wilbur B. Bowne, Michael Styler	6
12	Pancreatic mucinous cystic neoplasm in a transgender patient 2015 ·World Journal of Surgical Oncology ·Deshka S. Foster, (unknown), Elizabeth Gleeson, (unknown), Jianping Lin, Robert T. Ownbey, (unknown), Daniel A. Ringold, Wilbur B. Bowne	3
13	Anti-cancer Peptides from Ras-P21 and P53 Proteins 2011 ·Current Pharmaceutical Design ·Matthew R. Pincus, Maly Fenelus, (unknown), Victor Adler, Wilbur B. Bowne, Josef Michl	3
14	PNC-27 and PNC-28 anticancer peptides selectively kill cancer cells by pore formation dependent on the binding of these peptides to hdm2 in cancer cell membranes. 2008 ·Cancer Research ·(unknown), Wilbur B. Bowne, Victor Adler, (unknown), (unknown), (unknown), (unknown), (unknown), Paul W. Brandt‐Rauf, R. Fine, Fred K. Friedman, Michael E. Zenilman, Josef Michl, Matthew R. Pincus	1
15	The Penetratin Sequence in the Anticancer PNC-28 Peptide Causes Tumor Cell Necrosis Rather Than Apoptosis of Human Pancreatic Cancer Cells 2008 ·Annals of Surgical Oncology ·Wilbur B. Bowne, (unknown), (unknown), Victor Adler, (unknown), (unknown), (unknown), (unknown), M. Kamran Ikram, Michael A. Harding, Martin H. Bluth, (unknown), Paul W. Brandt‐Rauf, (unknown), (unknown), Michael E. Zenilman, Josef Michl, Matthew R. Pincus	13
16	Medial-to-lateral laparoscopic colon resection: a view beyond the learning curve 2007 ·Surgical Endoscopy ·(unknown), Eric D. Edwards, Wilbur B. Bowne, (unknown), (unknown), Pratap Gadangi, George Ferzli	30
17	Papillary Phenotype Confers Improved Survival After Resection of Hilar Cholangiocarcinoma 2005 ·Annals of Surgery ·William R. Jarnagin, Wilbur B. Bowne, David S. Klimstra, Leah Ben‐Porat, Kevin K. Roggin, Karína Cymes, Yuman Fong, Ronald P. DeMatteo, (unknown), Jonathan Koea, Leslie H. Blumgart	131
18	Cystic lesions of the pancreas: Selection criteria for operative and nonoperative management in 209 patients 2003 ·Journal of Gastrointestinal Surgery ·Peter J. Allen, David P. Jaques, Michael I. D’Angelica, Wilbur B. Bowne, Kevin C. Conlon, Murray F. Brennan	96
19	The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. 1999 ·The Lancet ·Doug A. Brooks, Murray F. Brennan, Helen Lewis, Wilbur B. Bowne, Rubén Niesvizky, D Filippa, Bryan M. Burt	31
20	Tumor immunity and autoimmunity induced by immunization with homologous DNA. 1998 ·Journal of Clinical Investigation ·L W Weber, Wilbur B. Bowne, Jedd D. Wolchok, Roopa Srinivasan, Jie Qin, Y. Moroi, Raphael Clynes, Ping Song, J J Lewis, Alan N. Houghton	185

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact